OR WAIT null SECS
PatientsLikeMe has unveiled a suite of services for pharmaceutical companies that allows them to collaborate with patients on the design of clinical trials and other research.
PatientsLikeMe has unveiled a suite of services for pharmaceutical companies that allows them to collaborate with patients on the design of clinical trials and other research. The announcement was made at the 50th annual meeting of the Drug Information Association (DIA) in San Diego, where global leaders in drug development and regulation are discussing new ways to accelerate the development of patient-centered health solutions.
Vice President of Innovation Paul Wicks, Ph.D. said that with more than 250,000 members reporting on their experiences with 2,000 diseases, PatientsLikeMe has transformed the way patients can shape research. “We’ve nurtured an open, data-sharing environment where members share their experiences to live better, and built a foundation for pharma-patient partnerships that can truly advance medicine. By listening to patients, we can create actionable insights that optimize the design of trial protocols and bring about better treatments, faster.”
The launch comes as results from a March 2014 survey of PatientsLikeMe members reveal just how broken the trial process is, and how eager patients are to help fix it. Members were asked about their attitudes toward, experiences with and criteria for participating in clinical trials. Of 1,621 survey respondents:
The full survey results are being presented at DIA’s Professional Poster Session at location T44 on Tuesday, June 17, 2014.
PatientsLikeMe announced three services at DIA:
For more information, visit